Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...
About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...
MOUNTAIN VIEW , CA, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Renaissance Healthcare for Women, led by ...
Please provide your email address to receive an email when new articles are posted on . The addition of Duchenne and metachromatic leukodystrophy allows for early detection and treatment. Advocacy ...
Skeletal muscle cells are widespread across a range of species, from simpler organisms such as cnidarians to higher vertebrates. They represent the most considerable tissue in the body by mass and ...
Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...
Psychologists and technologists see them as the future of therapy. The Food and Drug Administration is exploring whether to regulate them as medical devices. Psychologists and technologists see them ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine a newly revealed technique in ...
The US Supreme Court heard a case Tuesday that will determine whether a Colorado law that prohibits licensed mental health professionals from providing conversion “therapy” to minors is constitutional ...
Non-exclusive license for Solid Biosciences’ proprietary, next-generation myotropic capsid, AAV-SLB101, to accelerate development of KNA-155 for dysferlinopathy SEATTLE--(BUSINESS WIRE)--Kinea Bio Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results